首页> 外文期刊>Journal of the Association of Physicians of India >Role of Diagnostic Splenectomy in Patients Presenting with Pyrexia of Unknown Origin with Splenomegaly and Non-Contributory Pre-surgical Evaluation
【24h】

Role of Diagnostic Splenectomy in Patients Presenting with Pyrexia of Unknown Origin with Splenomegaly and Non-Contributory Pre-surgical Evaluation

机译:诊断脾切除术在患有脾肿大的未知渊源胃癌患者中的作用及非贡献前手术评估

获取原文
           

摘要

Aims: To describe the clinical and laboratory profile, post-surgical complicationsand longitudinal outcomes in a historical cohort of pyrexia of unknown origin(PUO) patients with splenomegaly who underwent a diagnostic splenectomyfollowing non-contributory extensive pre-surgical laboratory and radiologicalevaluation.Materials and Methods: This retrospective study was conducted in a 2700 bedteaching hospital in South India, in eligible patients, over a 10-year period.Results: Out of 38 PUO patients who underwent diagnostic splenectomy, a finaldiagnosis was established in 30 patients. Overall, infections contributed to 44 %(13/30), and neoplasia to 56% (17/30) of all cases. Of PUO patients with infections3/13 (23%) were diagnosed with disseminated tuberculosis, 7/13 (54%) withmelioidosis, 1/13 (8%) with Candidal splenic abscess with infective endocarditisand 2/13 (15%) with Colistin-resistant E. coli splenic abscess. Amongst PUOpatients with neoplasia (17/30), all patients were diagnosed with hematologicalneoplasia. Of these 94% (16/17) were diagnosed with Non-Hodgkin’s lymphomaand 6% (1/17) with Hodgkin’s disease. Splenectomy was non-contributory in 21%(8/38) patients. Post-operative complications were seen in 6/38 patients whorequired monitoring in the intensive care unit (ICU).In-hospital mortality wasnoted in 10.5% (4/38) patients.Conclusions: Diagnostic splenectomy has high diagnostic utility in the evaluationof PUO patients with reticuloendothelial system involvement after an extensivenegative investigative workup. The diagnosis of lymphoma in such patients ismore common than an infective cause.
机译:目的:描述临床和实验室简介,手术后并发症和纵向成果,在未知起源(Puo)患者的历史队列(Puo)患者患有脾肿大的患者,他们接受了诊断的脾肠杆切除的非缴费性广泛的手术实验室和辐射性高位。材料和方法:这项回顾性研究是在南印度的2700家床上医院进行,在符合条件的患者中,超过10年。结果:在38例损伤患者中,在30名患者中建立了终身诊断。总体而言,感染导致44%(13/30)和肿瘤到所有病例的56%(17/30)。呕吐痘痘患者3/13(23%)被诊断患有散发的结核病,7/13(54%)用潜水蛋白,1/13(8%),含有Colistin和Colistin的感染性心内膜炎和2/13(15%)抗大肠杆菌脾脓肿。患有肿瘤(17/30)的预诊断,所有患者均被诊断为血液管膜。其中94%(16/17)被诊断出与非霍奇金的淋巴瘤6%(1/17)诊断出霍奇金氏病。脾切除术在21%(8/38)患者中是非贡献。 6/38名患者的后期术后并发症在重症监护病房(ICU)中进行Worcorequired监测。在10.5%(4/38)患者中,在10.5%(4/38)患者中未发育的死亡率。结论:诊断脾脏切除术在Puo患者的评估中具有高诊断效用在延长的针对性调查次疗法后,具有网状内皮系统的参与。在这些患者中淋巴瘤的诊断比感染原因常见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号